Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Clinical trial NCT02180763 · COMPLETED

Trial details

NCT number: NCT02180763
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Immunodeficiency (PID)

Start date: 2014-04-01
Primary completion: 2016-08-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.